Simultaneous multianalyte ELISA performed on a microarray platform.

BACKGROUND A logical progression of the widely used microtiter plate ELISA is toward a protein array format that allows simultaneous detection of multiple analytes at multiple array addresses within a single well. Here we describe the construction and use of such a multiplex ELISA to measure prostate-specific antigen (PSA), alpha1-antichymotrypsin-bound PSA (PSA-ACT), and interleukin-6 (IL-6). METHODS We silanized glass plates and printed the appropriate capture antibodies to allow for the construction of "sandwich" ELISA quantification assays. We examined specificity of the assay for appropriate antigen, assembled calibration curves, and obtained PSA concentrations for 14 human serum samples. We compared the serum PSA concentrations derived through the use of our array with values obtained independently using a standard ELISA method. RESULTS R2 values generated by our microarray for the PSA and PSA-ACT calibration curves were 0.989 and 0.979, respectively. Analyte concentrations used for the construction of these curves were 0.31-20 microg of protein/L of diluent. IL-6 calibration curve concentrations were 4.9-300 ng of IL-6/L of diluent. The R2 value for the IL-6 calibration curve was 0.983. The 14 human serum samples screened by this micro-ELISA technique for PSA concentrations generated a regression equation (linear) with a slope of 0.83 +/- 0.10 and intercept of 0.74 +/- 0.70 (R2 = 0.88). CONCLUSIONS Multiplexed ELISA arrays are a feasible option for analyte quantification in complex biologic samples.

[1]  F W Chu,et al.  Multianalyte microspot immunoassay--microanalytical "compact disk" of the future. , 1991, Clinical chemistry.

[2]  John W. Silzel,et al.  Mass-sensing, multianalyte microarray immunoassay with imaging detection. , 1998, Clinical chemistry.

[3]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[4]  F. Collins Microarrays and macroconsequences , 1999, Nature Genetics.

[5]  A. Scorilas,et al.  Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays. , 2000, Clinical chemistry.

[6]  K. Pettersson,et al.  Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 alpha-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots. , 1992, Clinical chemistry.

[7]  R. Ekins,et al.  Ligand assays: from electrophoresis to miniaturized microarrays. , 1998, Clinical chemistry.

[8]  M. Kattan,et al.  Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. , 1999, The Journal of urology.

[9]  R Ekins,et al.  Microarrays: their origins and applications. , 1999, Trends in biotechnology.

[10]  H. Lehrach,et al.  Protein microarrays for gene expression and antibody screening. , 1999, Analytical biochemistry.

[11]  L. G. Mendoza,et al.  High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). , 1999, BioTechniques.

[12]  S. Loening,et al.  Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications. , 2000, Clinical chemistry.

[13]  E. Southern,et al.  Molecular interactions on microarrays , 1999, Nature Genetics.

[14]  C. Martelet,et al.  New use of cyanosilane coupling agent for direct binding of antibodies to silica supports. Physicochemical characterization of molecularly bioengineered layers. , 1999, Bioconjugate chemistry.

[15]  E. Diamandis,et al.  Preliminary examination of time-resolved fluorometry for protein array applications. , 2000, Luminescence : the journal of biological and chemical luminescence.

[16]  E. Diamandis,et al.  Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry. , 1992, Clinical chemistry.

[17]  H. Davies,et al.  Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays. , 1999, BioTechniques.

[18]  S. Loening,et al.  Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? , 2000, Clinical chemistry.

[19]  E. Lander Array of hope , 1999, Nature Genetics.